HomeOXB • LON
add
Oxford BioMedica plc
Nakaraang pagsara
GBX 575.00
Sakop ng araw
GBX 573.00 - GBX 582.00
Sakop ng taon
GBX 232.50 - GBX 660.00
Market cap
694.01M GBP
Average na Volume
303.98K
P/E ratio
-
Dividend yield
-
Primary exchange
LON
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (GBP) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 36.61M | 44.12% |
Gastos sa pagpapatakbo | 27.62M | 6.43% |
Net na kita | -13.18M | 18.85% |
Net profit margin | -36.00 | 43.70% |
Kita sa bawat share | — | — |
EBITDA | -7.07M | 37.05% |
Aktuwal na % ng binabayarang buwis | -3.25% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (GBP) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 53.88M | -33.82% |
Kabuuang asset | 216.32M | -11.70% |
Kabuuang sagutin | 183.59M | 5.66% |
Kabuuang equity | 32.73M | — |
Natitirang share | 106.14M | — |
Presyo para makapag-book | 18.55 | — |
Return on assets | -13.62% | — |
Return on capital | -21.33% | — |
Cash Flow
Net change in cash
| (GBP) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -13.18M | 18.85% |
Cash mula sa mga operasyon | 1.82M | 109.26% |
Cash mula sa pag-invest | -119.50K | -103.28% |
Cash mula sa financing | -5.08M | -203.78% |
Net change in cash | -3.39M | 69.64% |
Malayang cash flow | -2.64M | 68.87% |
Tungkol
Oxford Biomedica is a gene and cell therapy company specialising in the development of gene-based medicines. It is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index. Wikipedia
Itinatag
1995
Website
Mga Empleyado
900
